Prospective Study: The Effect on Clinical Outcome After Treatment of MTP Cartilage Lesions in Hallux Valgus Surgery
Launched by TOM LOOTENS · Jan 18, 2021
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how treating cartilage damage in the big toe joint affects the recovery of patients undergoing surgery for hallux valgus, commonly known as a bunion. The researchers want to find out if addressing this cartilage issue during surgery can improve the overall outcomes for patients. Currently, there aren’t clear guidelines on how to treat these cartilage lesions, so this study aims to fill that gap.
To participate in this study, individuals must be between 30 and 60 years old and diagnosed with hallux valgus. Unfortunately, those with other significant foot problems or who are outside this age range cannot take part. Participants can expect to undergo a surgical procedure and will be monitored to see how their recovery progresses after treatment. This trial is currently recruiting, and anyone interested should speak with their healthcare provider to learn more about joining.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • hallux valgus
- Exclusion Criteria:
- • younger than 30 years, older than 60 years
- • extra pathologies other than hallux valgus
About Tom Lootens
Tom Lootens is a dedicated clinical trial sponsor committed to advancing medical research and improving patient outcomes through innovative studies. With a focus on high-quality trial design and ethical practices, the organization collaborates with leading healthcare professionals and institutions to facilitate the development of new therapies. Leveraging a wealth of experience in the pharmaceutical and biotechnology sectors, Tom Lootens ensures that each trial is conducted with rigor and integrity, prioritizing participant safety and data integrity to contribute valuable insights to the medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Gent, , Belgium
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials